LifeCell Corporation
LifeCell develops and markets tissue repair products for use in reconstructive surgical procedures.
Our Vision
To be recognized by customers as the leader in regenerative medicine by providing innovative products for tissue restoration and replacement that deliver significant clinical benefits and economic value.
Our Mission
To advance the power of regenerative medicine.
Division Profile
LifeCell develops and markets tissue repair products for use in reconstructive, urogynecologic and orthopedic surgical procedures. LifeCell's current marketed products include: Strattice™ Reconstructive Tissue Matrix and AlloDerm® Regenerative Tissue Matrix, for plastic, reconstructive, general surgical, burn and periodontal procedures; Cymetra® Regenerative Tissue Matrix, a particulate form of AlloDerm® Tissue Matrix suitable for injection; Repliform® Regenerative Tissue Matrix, for urogynecologic surgical procedures; GraftJacket®, for orthopedic surgical procedures; and AlloCraft™DBM, for bone grafting procedures.
Currently marketed LifeCell products in the UK include:
- Strattice Reconstructive Tissue Matrix
This Web page contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use.